Hepatocyte-directed gene delivery by receptor-mediated endocytosis

Seminars in Liver Disease

Volumn 19, Issue 1, 1999, Pages 83-92

  Smith, Robert M ^a   Wu, George Y ^a,b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Gene therapy; Liposomes; Receptor mediated endocytosis

Indexed keywords

ALPHA 1 ANTITRYPSIN; ASIALOGLYCOPROTEIN RECEPTOR; CHOLESTEROL; LIPOSOME; LOW DENSITY LIPOPROTEIN RECEPTOR; ORNITHINE CARBAMOYLTRANSFERASE;

ALPHA 1 ANTITRYPSIN DEFICIENCY; CLONING VECTOR; CONJUGATE; CRIGLER NAJJAR SYNDROME; ENDOCYTOSIS; FAMILIAL HYPERCHOLESTEROLEMIA; GENE TARGETING; GENE THERAPY; GENETIC TRANSDUCTION; HEMOPHILIA B; HEPATITIS VIRUS; HUMAN; INBORN ERROR OF METABOLISM; LIVER CELL; LIVER DISEASE; LIVER METABOLISM; NONHUMAN; PRIORITY JOURNAL; REVIEW; TYROSINEMIA;

EID: 0032945030     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007100     Document Type: Review

References (107)

1. Nunes FA, Raper SE. Liver-directed gene therapy. Med Clin North Am 1996;80:1201-1213
2. Raper SE, Wilson JM. Gene therapy for human liver disease. Prog Liver Dis 1995;13:201-230
3. Kormis KK, Wu GY. Prospects of therapy of liver diseases with foreign genes. Semin Liver Dis 1995;15:257-267
4. Grossman M, Rader DJ, Muller DW, et al. A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolemia. Nat Med 1995;1:1148-1154
5. Alt M, Caselmann WH. Liver-directed gene therapy: Molecular tools and current preclinical and clinical studies. J Hepatol 1995;23:746-758
6. Chang AG, Wu GY. Gene therapy: Applications to the treatment of gastrointestinal and liver diseases. Gastroenterology 1994; 106:1076-1084
7. Sandig V, Strauss M. Liver-directed gene transfer and application to therapy. J Mol Med 1996;74:205-212
8. Miller N, Vile R. Targeted vectors for gene therapy. FASEB J 1995;9:190-199
9. Gunzburg WH, Fleuchaus A, Saller R, Salmons B. Retroviral vector targeting for gene therapy. Cytokines Mol Ther 1996;2: 177-184
10. Kay MA. Adenoviral vectors for hepatic gene transfer in animals. Chest 1997;111:138S-142S
11. Gerard RD, Chan L. Adenovirus-mediated gene transfer: Strategies and applications in lipoprotein research. Curr Opin Lipidol 1996;7:105-111
12. Mahato RI, Takakura Y, Hashida M. Nonviral vectors for in vivo gene delivery: Physicochemical and pharmacokinetic considerations. Crit Rev Ther Drug Carrier Syst 1997;14:133-172
13. Ledley FD. Nonviral gene therapy: The promise of genes as pharmaceutical products. Hum Gene Ther 1995;6:1129-1144
14. Wu J, Zern MA. Modification of liposomes for liver targeting. J Hepatol 1996;24:757-763
15. Phillips SC. Receptor-mediated DNA delivery approaches to human gene therapy. Biologicals 1995;23:13-16
16. Miller N, Whelan J. Progress in transcriptionally targeted and regulatable vectors for genetic therapy. Hum Gene Ther 1997;8: 803-815
17. Kato Y, Sugiyama Y. Targeted delivery of peptides, proteins, and genes by receptor-mediated endocytosis. Crit Rev Ther Drug Carrier Syst 1997;14:287-331
18. Cristiano RJ, Curiel DT. Strategies to accomplish gene delivery via the receptor-mediated endocytosis pathway. Cancer Gene Ther 1996;3:49-57
19. Mukherjee S, Ghosh RN, Maxfield FR. Endocytosis. Physiol Rev 1997;77:759-803
20. Schwartz AL. Receptor cell biology: Receptor-mediated endocytosis. Pediatr Res 1995;38:835-843
21. Cooper AD. Hepatic uptake of chylomicron remnants. J Lipid Res 1997;38:2173-2192
22. Stockert RJ. The asialoglycoprotein receptor: Relationships between structure, function, and expression. Physiol Rev 1995;75: 591-609
23. Franssen EJ, Jansen RW, Vaalburg M, Meijer DK. Hepatic and intrahepatic targeting of an anti-inflammatory agent with human serum albumin and neoglycoproteins as carrier molecules. Biochem Pharmacol 1993;45:1215-1226
24. Nishikawa M, Kamijo A, Fujita T, Takakura Y, Sezaki H, Hashida M. Synthesis and pharmacokinetics of a new liver-specific carrier, glycosylated carboxymethyl-dextran, and its application to drug targeting. Pharm Res 1993;10:1253-1261
25. Lee RJ, Huang L. Lipidic vector systems for gene transfer. Crit Rev Ther Drug Carrier Syst 1997;14:173-206
26. Wrobel I, Collins D. Fusion of cationic liposomes with mammalian cells occurs after endocytosis. Biochim Biophys Acta 1995;1235:296-304
27. Saeki Y, Matsumoto N, Nakano Y, Mori M, Awai K, Kaneda Y. Development and characterization of cationic liposomes conjugated with HJV (Sendai virus): Reciprocal effect of cationic lipid for in vitro and in vivo gene transfer. Hum Gene Ther 1997;8: 2133-2141
28. Hara T, Kuwasawa H, Aramaki Y, et al. Effects of fusogenic and DNA-binding amphiphilic compounds on the receptor-mediated gene transfer into hepatic cells by asialofetuin-labeled liposomes. Biochim Biophys Acta 1996;1278:51-58
29. Madon J, Blum HE. Receptor-mediated delivery of hepatitis B virus DNA and antisense oligodeoxynucleotides to avian liver cells. Hepatology 1996;24:474-481
30. Wu G, Zhan P, Sze LL, Rosenberg AR, Wu CH. Incorporation of adenovirus into a ligand-based DNA carrier system results in retention ot original receptor specificity and enhances targeted gene expression. J Biol Chem 1994;269:11542-11546
31. Wattiaux R, Jadot M, Warnier-Pirotte MT, Wattiaux-De Coninck S. Cationic lipids destabilize lysosomal membrane in vitro. FEBS Lett 1997;417:199-202
32. Chowdhury NR, Hays RM, Bommineni VR, et al. Microtubular disruption prolongs the expression of human bilirubin-uridinediphosphoglucuronate-glucuronosyltransferase-1 gene transferred into Gunn rat livers. J Biol Chem 1996;271:2341-2346
33. Bommineni VR, Chowdhury NR, Wu GY, et al. Depolymerization of hepatocellular microtubules after partial hepatectomy. J Biol Chem 1994;269:25200-25205
34. Chowdhury NR, Wu CH, Wu GY, Yerneni PC, Bommineni VR, Chowdhury JR. Fate of DNA targeted to the liver by asialoglycoprotein receptor-mediated endocytosis in vivo. Prolonged persistence in cytoplasmic vesicles after partial hepatectomy. J Biol Chem 1993;268:11265-11271
35. Wilson JM, Grossman M, Cabrera JA, Wu CH, Wu GY. A novel mechanism for achieving transgene persistence in vivo after somatic gene transfer into hepatocytes. J Biol Chem 1992;267: 11483-11489
36. Kitten O, Cosset FL, Ferry N. Highly efficient retrovirus-mediated gene transfer into rat hepatocytes in vivo. Hum Gene Ther 1997;8:1491-1494
37. Li Q, Kay MA, Finegold M, Stratford-Perricaudet LD, Woo SL. Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum Gene Ther 1993;4:403-409
38. Peeters MJ, Patijn GA, Lieber A, Meuse L, Kay MA. Adenovirus-mediated hepatic gene transfer in mice: Comparison of intravascular and biliary administration. Hum Gene Ther 1996; 7:1693-1699
39. Sandig V, Loser P, Lieber A, Kay MA, Strauss M. HBV-derived promoters direct liver-specific expression of an adenovirally transduced LDL receptor gene. Gene Ther 1996;3:1002-1009
40. Krasnykh V, Dmitriev I, Mikheeva G, Miller CR, Belousova N, Curiel DT. Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. J Virol 1998;72:1844-1852
41. Wickham TJ, Tzeng E, Shears LL 2nd. et al. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J Virol 1997;71:8221-8229
42. Stevenson SC, Rollence M, Marshall-Neff J, McClelland A. Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein. J Virol 1997;71:4782-4790
43. Krasnykh VN, Mikheeva GV, Douglas JT, Curiel DT. Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J Virol 1996;70:6839-6846
44. Wickham TJ, Carrion ME, Kovesdi I. Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. Gene Ther 1995;2:750-756
45. Rogers BE, Douglas JT, Ahlem C, Buchsbaum DJ, Frincke J, Curiel DT. Use of a novel cross-linking method to modify adenovirus tropism. Gene Ther 1997;4:1387-1392
46. Watkins SJ, Mesyanzhinov VV, Kurochkina LP, Hawkins RE. The adenohody approach to viral targeting: Specific and enhanced adenoviral gene delivery. Gene Ther 1997;4:1004-1012
47. Wickham TJ, Segal DM, Reolvink PW, et al. Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies. J Virol 1996;70:6831-6838
48. Tada K, Chowdhury NR, Neufeld D, et al. Long-term reduction of serum bilirubin levels in Gunn rats by retroviral gene transfer in vivo. Liver Transplant Surg 1998;4:78-88
49. Okuyama T, Huber RM, Bowling W, et al. Liver-directed gene therapy: A retroviral vector with a complete LTR and the ApoE enhancer-alpha 1-antitrypsin promoter dramatically increases expression of human alpha 1-antitrypsin in vivo. Hum Gene Ther 1996;7:637-645
50. Povedin G, Ferry N, Calise D, Revillion Y. In vivo retroviral-mediated transfer of a marker-gene in ornithine transcarbamylase-deficient Spf(ash) mice. J Pediatr Surg 1996;31:1516-1519
51. Connelly S, Andrews JL, Gallo AM, et al. Sustained phenotypic correction of murine hemophilia A by in vivo gene therapy. Blood 1998;91:3273-3281
52. van Dijk KW, van Vlijmen BJ, van der Zee A, et al. Reversal of hypercholesterolemia in apolipoprotein E2 and apolipoprotein E3-Leiden transgenic mice by adenovirus-mediated gene transfer of the VLDL receptor. Arterioscler Thromb Biol 1998; 18:7-12
53. Li O, Murphree SS, Willer SS, Bolli R, French BA. Gene therapy with bilirubin-UDP-glucuronosyltransferase in the Gunn rat model of Crigler-Najjar syndrome type 1. Hum Gene Ther 1998; 9:497-505
54. Ohashi T, Watabe K, Uehara K, Sly WS, Vogler C, Eto Y. Adenovirus-mediated gene transfer and expression of human beta-glucuronidase gene in the liver, spleen, and central nervous system in mucopolysaccharidosis type VII mice. Proc Natl Acad Sci U S A 1997;94:1287-1292
55. Zsigmond E, Kobayashi K, Tzung KW, Li L, Fuke Y, Chan L. Adenovirus-mediated gene transfer of human lipoprotein lipase ameliorates the hyperlipidemias associated with apolipoprotein E and LDL receptor deficiencies in mice. Hum Gene Ther 1997; 8:1921-1933
56. Eisensmith RC, Woo SLC. Somatic gene therapy for phenylketonuria and other hepatic deficiencies. J Inher Metab Dis 1996; 19:412-423
57. Kiwaki K, Matsuda I. Gene therapy for ornithine transcarbamylase deficiency. Acta Paediatr Jpn 1996;38:189-192
58. Piedra PA, Poveda GA, Ramsey B, McCoy K, Hiatt PW. Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: Implication for gene therapy with adenovirus vectors. Pediatrics 1998;101: 1013-1019
59. Yang Y, Jooss KU, Su Q, Ertl HC, Wilson JM. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther 1996;3:137-144
60. Yang Y, Ertl HC, Wilson JM. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1994;1:433-442
61. Crystal RG, McElvaney NG, Rosenfeld MA, et al. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet 1994;8:42-51
62. Bowling WM, Kennedy SC, Cai SR, et al. Portal branch occlusion safely facilitates in vivo retroviral vector transduction of rat liver. Hum Gene Ther 1996;7:2113-2121
63. Pages JC, Loux N, Bellusci S, et al. Hepatocyte growth factor expressed by a retrovirus-producing cell line enhances retroviral transduction of primary hepatocytes: Implications for in vivo gene transfer. Biochem Biophys Res Commun 1996;222:726-731
64. Overturf K, Al-Dhalimy M, Tanguay R, et al. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Nat Genet 1996;12:266-273
65. Lieber A, Vrancken Peeters MJ, Meuse L, Fausto N, Perkins J, Kay MA. Adenovirus-mediated urokinase gene transfer induces liver regeneration and allows for efficient retrovirus transduction of hepatocytes in vivo. Proc Natl Acad Sci U S A 1995;92:6210-6214
66. Wang Q, Greenburg G, Bunch D, Farson D, Finer MH. Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector. Gene Ther 1997;4:393-400
67. Wolff G, Worgall S, van Rooijen N, Song WR, Harvey BG, Crystal RG. Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ. J Virol 1997;71:624-629
68. Gao GP. Yang Y, Wilson JM. Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J Virol 1996;70:8934-8943
69. Yang Y, Greenough K, Wilson JM. Transient immune blockade prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse liver. Gene Ther 1996;3:412-420
70. Wu G, Wu C. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J Biol Chem 1987;262:4429-4432
71. Wu GY, Wu CH. Receptor-mediated gene delivery and expression in vivo. J Biol Chem 1988;263:14621-14624
72. Wu CH, Wilson JM, Wu GY. Targeting genes: Delivery and persistent expression of a foreign gene driven by mammalian regulatory elements in vivo. J Biol Chem 1989;264:16985-16987
73. Wu GY, Wilson JM, Shalaby F, Grossman M, Shafritz DA, Wu CH. Receptor-mediated gene delivery in vivo. J Biol Chem 1991;266:14338-14342
74. Treichel U, Meyer zum Buschenfelde KH, Dienes HP, Gerken G. Receptor-mediated entry of hepatitis B virus particles into liver cells. Arch Virol 1997;142:493-498
75. Treichel U, Meyer zum Buschenfelde KH, Stockert RJ, Poralla T, Gerken G. The asialoglycoprotein receptor mediates hepatic binding and uptake of natural hepatitis B virus particles derived from viraemic carriers. J Gen Virol 1994;75:3021-3029
76. Sandig V, Hofmann C, Loser P, Jennings G, Strauss M. Gene therapy: Prospects for treatment of liver disease. Z Gastroenterol 1996;34(suppl 3):25-26
77. Zanta MA, Boussif O, Adib A, Behr JP. In vitro gene delivery to hepatocytes with galactosylated polyethylenimine. Bioconjug Chem 1997;8:839-844
78. Boussif O, Lezoualc'h F, Zanta MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc Natl Acad Sci U S A 1995;92: 7297-7301
79. Perales JC, Grossmann GA, Molas M, et al. Biochemical and functional characterization of DNA complexes capable of targeting genes to hepatocytes via the asialoglycoprotein receptor. J Biol Chem 1997;272:7398-7407
80. Perales JC, Ferkol T, Beegen H, Ratnoff OD, Hanson RW. Gene transfer in vivo: Sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake. Proc Natl Acad Sci U S A 1994;91:4086-4090
81. Bijsterbosch MK, van Berkel TJC. Uptake of lactosylated low-density lipoprotein by galactose-specific receptors in rat liver. Biochem J 1990;270:233-239
82. Gao X, Huang L. Cationic liposome-mediated gene transfer. Gene Ther 1995;2:710-722
83. Caplen NJ, Alton EW, Middleton PG, et al. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat Med 1995;1:39-46
84. Nabel GJ, Nabel EG, Yang ZY, et al. Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci U S A 1993;90:11307-11311
85. Litzinger DC, Brown JM, Wala I, et al. Fate of cationic liposomes and their complex with oligonucleotide in vivo. Biochim Biophys Acta 1996;1281:139-149
86. McLean JW, Fox EA, Baluk P, et al. Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice. Am J Physiol 1997;273:H387-404
87. Hu Q, Liu D. Co-existence of serum-dependent and serum-independent mechanisms for liposome clearance and involvement of non-Kupffer cells in liposome uptake by mouse liver. Biochim Biophys Acta 1996;1284:153-161
88. Alino SF, Bobadilla M, Crespo J, Lejarreta M. Human alpha 1-antitrypsin gene transfer to in vivo mouse hepatocytes. Hum Gene Ther 1996;7:531-536
89. Yu HY, Lin CY. Uptake of charged liposomes by the rat liver. J Formos Med Assoc 1997;96:409-413
90. Alino SF. Long-term expression of the human alpha 1-anthrypsin gene in mice employing anionic and cationic liposome vector. Biochem Pharmacol 1997;54:9-13
91. Liu F, Qi H, Huang L, Liu D. Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration. Gene Ther 1997;4:517-523
92. Theirry AR, Rabinovich P, Peng B, Mahan LC, Bryant JL, Gallo RC. Characterization of liposome-mediated gene delivery: Expression, stability and pharmacokinetics of plasmid DNA. Gene Ther 1997;4:226-237
93. Wilke M, Bijma A, Timmers-Reker AJ, Scholte BJ, Sinaasappel M. Complementation of the genetic defect in Gunn rat hepatocytes in vitro by highly efficient gene transfer with cationic liposomes. Gene Ther 1997;4:1305-1312
94. Liu F, Liu D. Serum independent liposome uptake by mouse liver. Biochim Biophys Acta 1996;1278:5-11
95. Shimizu H, Kumai K, Uyama I, et al. Improvement of pharmacokinetics and antitumor activity against human hepatoma cell line by using adriamycin-entrapped stealth liposomes. J Surg Oncol 1996;62:186-193
96. Yoshikawa Y, Miyazaki M, Houjou T. Komuta Y, Yoshikawa H, Takada K. Biodistribution of cyclosporin encapsulated in liposomes modified with bioadhesive polymer. J Pharm Pharmacol 1997;49:661-668
97. Koike K, Hara T, Aramaki Y, Takada S, Tsuchiya S. Receptor-mediated gene transfer into hepatic cells using asialoglycoprotein-labeled liposomes. Ann N Y Acad Sci 1994;716:331-333
98. Hara T, Aramaki Y, Takada S, Koike K, Tsuchiya S. Receptor-mediated transfer of pSV2CAT DNA to mouse liver cells using asialofetuin-labeled liposomes. Gene Ther 1995;2:784-788
99. Wu J, Liu P, Zhu JL, Maddukuri S, Zern MA. Increased liver uptake of liposomes and improved targeting efficacy by labeling with asialofetuin in rodents. Hepatology 1998;27:772-778
100. Murahashi N, Ishihara H, Sasaki A, Sakagami M, Hamana H. Hepatic accumulation of glutamic acid branched neogalactosyl-lipid modified liposomes. Biol Pharm Bull 1997;20:259-266
101. Shimada K, Kamps JA, Regts J, et al. Biodistribution of liposomes containing synthetic galactose-terminated diacylglyceryl-poly(ethyleneglycol)s. Biochim Biophys Acta 1997;1326:329-341
102. Shimizu K, Maitani Y, Takayama K, Nagai T. Formulation of liposomes with a soybean-derived stearylglucoside mixture and cholesterol for liver targeting. Biol Pharm Bull 1997;20:881-886
103. Fonseca MJ, Alsina MA, Reig F. Coating liposomes with collagen (Mr 50,000) increases uptake into liver. Biochim Biophys Acta 1996;1279:259-265
104. Kamps JA, Morselt HW, Swart PJ, Meijer DK, Scherphof GL. Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells. Proc Natl Acad Sci U S A 1997:94:11681-11685
105. Huwyler J, Yang J, Pardridge WM. Receptor mediated delivery of daunomycin using immunoliposomes: Pharmacokinetics and tissue distribution in the rat. J Pharmacol Exp Ther 1997;282: 1541-1546
106. Rensen PCN, Schiffelers RM, Versluis AJ, Bijsterbosch MK, Van Kuijk-Meuwissen ME, Van Berkel TJ. Human recombinant apolipoprotein E-enriched liposomes can mimic low-density lipoproteins as carriers for the site-specific delivery of antitumor agents. Mol Pharmacol 1997;52:445-455
107. Goldman CK, Soroceanu L, Smith N, et al. In vitro and in vivo gene delivery mediated by a synthetic polycationic amino polymer. Nat Biotechnol 1997;15:462-466